Search Result "Tumour reversion"
Immunity to Tumour Antigens
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3501-3509
Author(s): G. Li, S. A. Ali, S. E.B. McArdle, S. Mian, M. Ahmad, A. Miles, R. C. Rees
Passive and Active Tumour Targeting with Nanocarriers
Journal: Current Drug Discovery Technologies
Volume: 8 Issue: 3 Year: 2011 Page: 188-196
Author(s): Samuli Hirsjarvi, Catherine Passirani, Jean-Pierre Benoit
Tumor Reversion: Mesenchymal-Epithelial Transition as a Critical Step in Managing the Tumor-Microenvironment Cross-Talk
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 32 Year: 2017 Page: 4705-4715
Author(s): Mariano Bizzarri,Alessandra Cucina,Sara Proietti
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
Journal: Current Radiopharmaceuticals
Volume: 12 Issue: 2 Year: 2019 Page: 126-134
Author(s): Shahad Alsadik,Siraj Yusuf,Adil AL-Nahhas
Tumour Reactions to Hypoxia
Journal: Current Molecular Medicine
Volume: 10 Issue: 4 Year: 2010 Page: 381-386
Author(s): M.J. Voss, B. Niggemann, K.S. Zanker, F. Entschladen
Chromatin Structure and Epigenetics of Tumour Cells: A Review
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 51-61
Author(s): Eva Bartova, Jana Krejci, Roman Hajek, Andrea Harnicarova, Stanislav Kozubek
Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 1158-1183
Author(s): Nazila Kamaly, Andrew D. Miller, Jimmy D. Bell
Enzymes: Tumour Associated Biomarker
Ebook: Current Cancer Biomarkers
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815079364123010012
Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6 Issue: 1 Year: 2011 Page: 31-40
Author(s): Elizabeth Harford-Wright, Kate M. Lewis, Robert Vink
Prospects of Reverse Transcriptase Inhibitors
Ebook: Frontiers in Clinical Drug Research: HIV
Volume: 3 Year: 2016
Author(s): Chang Liu,Xiaohong Kong
Doi: 10.2174/9781681082295116030007